BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 1436452)

  • 21. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of tumor progression by signal intensity increase on fluid-attenuated inversion recovery magnetic resonance images in the resection cavity of high-grade gliomas.
    Ito-Yamashita T; Nakasu Y; Mitsuya K; Mizokami Y; Namba H
    Neurol Med Chir (Tokyo); 2013; 53(7):496-500. PubMed ID: 23883561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI characterization of 9L-glioma in rat brain at 4.7 Tesla.
    Rajan SS; Rosa L; Francisco J; Muraki A; Carvlin M; Tuturea E
    Magn Reson Imaging; 1990; 8(2):185-90. PubMed ID: 2338899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of contrast media in MRI at 0.02 T. A preliminary report.
    Kormano M; Niemi P; Paajanen H; Määttänen H; Katevuo K
    Invest Radiol; 1988 Sep; 23 Suppl 1():S289-91. PubMed ID: 3198364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Data-driven grading of brain gliomas: a multiparametric MR imaging study.
    Caulo M; Panara V; Tortora D; Mattei PA; Briganti C; Pravatà E; Salice S; Cotroneo AR; Tartaro A
    Radiology; 2014 Aug; 272(2):494-503. PubMed ID: 24661247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain abscess and cystic brain tumor: discrimination with dynamic susceptibility contrast perfusion-weighted MRI.
    Erdogan C; Hakyemez B; Yildirim N; Parlak M
    J Comput Assist Tomogr; 2005; 29(5):663-7. PubMed ID: 16163039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy.
    Pirzkall A; Nelson SJ; McKnight TR; Takahashi MM; Li X; Graves EE; Verhey LJ; Wara WW; Larson DA; Sneed PK
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1254-64. PubMed ID: 12128127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delineation of gliomas with various doses of MR contrast material.
    Yuh WT; Nguyen HD; Tali ET; Mayr NA; Fisher DJ; Atlas SW; Carvlin MC; Drayer BP; Pollei SR; Runge VM
    AJNR Am J Neuroradiol; 1994 May; 15(5):983-9. PubMed ID: 8059672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A magnetic resonance imaging contrast agent differentiates between the vascular properties of fetal striatal tissue transplants and gliomas in rat brain in vivo.
    Norman AB; Thomas SR; Pratt RG; Samaratunga RC; Sanberg PR
    Brain Res; 1989 Nov; 503(1):156-9. PubMed ID: 2611648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of diffusion tensor imaging in preoperation and postoperation patients of glioma with 3.0 Tesla MRI].
    Li X; Yu RT; Xu K; Li FC; Fan YC; Gao WC; Guo KQ; Pan X; Yang C
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1300-4. PubMed ID: 19615179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
    Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
    Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 111Indium (DTPA-octreotide) scintigraphy in patients with cerebral gliomas.
    Luyken C; Hildebrandt G; Scheidhauer K; Krisch B; Schicha H; Klug N
    Acta Neurochir (Wien); 1994; 127(1-2):60-4. PubMed ID: 7942184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data.
    Zetterling M; Roodakker KR; Berntsson SG; Edqvist PH; Latini F; Landtblom AM; Pontén F; Alafuzoff I; Larsson EM; Smits A
    J Neurosurg; 2016 Nov; 125(5):1155-1166. PubMed ID: 26918468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion?
    Price SJ; Burnet NG; Donovan T; Green HA; Peña A; Antoun NM; Pickard JD; Carpenter TA; Gillard JH
    Clin Radiol; 2003 Jun; 58(6):455-62. PubMed ID: 12788314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
    Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
    J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small gliomas: clinicopathological study.
    Tamura M; Ono N; Zama A; Ishiuchi S; Kawashima Y
    Neurol Med Chir (Tokyo); 1993 Jul; 33(7):425-8. PubMed ID: 7692318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignancy and viability of intraparenchymal brain tumours: correlation between Gd-DTPA contrast MR images and proliferative potentials.
    Yoshii Y; Komatsu Y; Yamada T; Hyodo A; Nose T; Kobayashi E
    Acta Neurochir (Wien); 1992; 117(3-4):187-94. PubMed ID: 1414520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.